Having trouble accessing articles? Reset your cache.

Management tracks: PhRMA, Arcus, Beam, Stealth, Bolt, Athenex, Click, Melinta, Kallyope and Genor

PhRMA said that Giovanni Caforio, who was chairman-elect, will become chairman of PhRMA's board. Caforio is chairman and CEO of Bristol-Myers Squibb Co. (NYSE:BMY) and succeeds Olivier Brandicourt, who stepped down as CEO

Read the full 338 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers